UK Dementia partnership offering £100,000-200,000 awards for dementia research projects
October 23, 2018Manufacturing and Production Alzheimer's, dementia, development, research
The Dementia Discovery Fund (DDF) in partnership with the UK Dementia Research Institute (UK DRI) has announced that it will …
J&J announce promising Phase 1/2a results for HIV vaccine
October 23, 2018Manufacturing and Production AIDS, HIV, J&J, JJ, Vaccine, infectious diseases
The world may be one step closer to discovering a preventative vaccine for HIV following American multinational Johnson & Johnson’s …
Roche’s Tecentriq+chemo boosts survival in first-line non-small cell lung cancer
October 22, 2018Research and Development, Sales and Marketing Cancer, Roche, lung cancer NSCLC, pharma, tecentriq
Roche joined other major players like Bristol-Myers Squibb in revealing strong data on their cancer immunotherapies at the European Society …
Working Life: Joe Wiley, CEO, Amryt Pharma
October 22, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amryt Pharma, CEO, Ireland, Joe WIley, pharma
Pharmafocus talked to Joe Wiley, CEO and founder of Amryt Pharma as he retraced his journey from medical student in …
Takeda’s subcutaneous vedolizumab proves efficacious in Phase III trial for Ulcerative Colitis
October 22, 2018Sales and Marketing Takeda, UC, biologic, phase III, results, ulcerative colitis, vedolizumab
Japanese pharma firm Takeda has announced that the gut-selective biologic vedolizumab when taken as a subcutaneous (SC) injection, proved efficacious …
Janssen’s Tremfya maintains skin clearance after 3 years in plaque psoriasis
October 22, 2018Research and Development, Sales and Marketing Janssen, Tremfya, pharma, plaque psoriasis, psoriasis
Janssen has revealed new long-term data for its IL-23 inhibitor Tremfya (guselkumab) in moderate to severe plaque psoriasis, demonstrating skin …
BMS’ Opdivo and Yervoy combination shows outstanding survival rate in cancer patients
October 22, 2018Sales and Marketing BMS, Bristol-Myers Squibb, Cancer, Yervoy, melanoma, opdivo
American pharma firm Bristol-Myers Squibb have announced that more than 53% of patients with advanced melanoma, who were treated with …
GSK named third best UK workplace
October 22, 2018Sales and Marketing AbbVie, Amgen, BMS, Eli Lilly, GSK, J&J, JJ, work
British multinational GlaxoSmithKline has been rated as the third best company to work for in the UK, according to jobs …
MSD’s Keytruda with Pfizer’s Inlyta beats Sutent in most common kidney cancer
October 19, 2018Medical Communications, Research and Development Cancer, Kidney cancer, MSD, Pfizer, inlyta, keytruda, pharma
MSD has unveiled new Phase 3 data on its blockbuster anti-PD-1 cancer therapy Keytruda (pembrolizumab) as part of a combination, …
Top Ten most popular articles on Pharmafile.com this week
October 19, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, AstraZeneca, Bayer, Novartis, Samsung, Trump, biosimilars, brexit
Business, biosimilars and Brexit are the themes of this week’s top 10. While Roche signed a $1 billion deal with …
US FDA offers plan for global regulatory harmonisation for generic drugs
October 19, 2018Medical Communications FDA, ICH, generic drugs, harmonisation, regulatory bodies
The US Food and Drug Administration (FDA) is offering a proposal to the International Council on Harmonisation (ICH) aimed at …
NICE rejects Elil Lilly’s Verzenio for breast cancer in draft guidance
October 19, 2018Medical Communications, Sales and Marketing Eli Lilly, NICE, UK, Verzenios, breast cancer, pharma
Eli Lilly and patients with breast cancer patients in the UK have been dealt a blow as NICE confirmed that …
MSF warns of antibiotic resistance crisis in Gaza
October 19, 2018Medical Communications AMR, Gaza, MSF, Palestine, antibiotic resistance, israel
The international non-governmental organisation (NGO) Médecins Sans Frontières (MSF) has warned that antibiotic resistant infections are a “certainty” in Gaza. …
Robot addresses British MPs over future of AI
October 18, 2018Medical Communications AI, Robot, UK, artificial intelligence, british parliament
British MPs questioned the first robot to ever attend a UK parliamentary meeting this month, after a robot called Pepper …
Hearing loss and inner ear disorders: The next frontier for pharmaceutical success?
October 18, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sensorion, hearing loss, inner ear disorders, opinion, pharma
Nawal Ouzren, CEO of Sensorion, examines the latest therapies and developments emerging in the difficult-to-treat world of human ear disorders, …
GSK to axe 99 positions at Memphis site
October 18, 2018Manufacturing and Production GSK, US, pharma
GlaxoSmithKline’s workforce on President’s Island in Memphis, US, is set to see the loss of 99 employees, as revealed in …
Novartis snaps up cancer drug developer Endocyte for $2.1 billion
October 18, 2018Research and Development, Sales and Marketing Cancer, Endocyte, Novartis, pharma
Novartis will shell out $2.1 billion to acquire cancer drug developer Endocyte in a move to leverage the company’s technology …
MHRA to extend EpiPen expiry dates to tackle shortages
October 18, 2018Manufacturing and Production, Sales and Marketing ALK+, Denmark, Mylan, UK, alk, epipen
The British government has extended the expiry date on epinephrine pens amid a shortage in the UK. The Danish pharmaceutical …
Pfizer announce cull of 2% of staff
October 18, 2018Business Services, Medical Communications, Sales and Marketing Bourla, Ian Read, Jobs, Pfizer, america, layoffs
US pharma giant Pfizer is offering early retirement to American workers ahead of layoffs scheduled for next year. The company …
Researchers launch Phase 1 trial of HIV vaccine
October 18, 2018Research and Development AIDS, HIV, Vaccine, infection, resdearch
Researchers working with the non-profit organisation the International AIDS Vaccine Initiative (IAVI) have announced the launch of a Phase I …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
